Bioequivalence Study to Compare Selexipag 400 Microgram Film Coated Tablets Versus Uptravi® (Selexipag) 400 Microgram Film Coated Tablets

NCT07694128 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Arterial Hypertension (PAH)

Interventions

DRUG: Selexipag Film Coated Tablets (T1)
DRUG: Selexipag Film Coated Tablets (T2)
DRUG: Uptravi® (selexipag) film coated tablets

Sponsor

Humanis Saglık Anonim Sirketi